Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Insulin Glargine Dosing Study
NCT00309465Phase 4Completed
- Start
- Oct 2005
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in diabetes mellitus (DM) (3 arms). Primary endpoint: Preoperative Fasting Blood Sugar Upon Arrival at the Hospital Prior to Surgery at Day 1. Started Oct 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00309465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309465.